z-logo
open-access-imgOpen Access
Echoviruses and Coxsackie B Viruses That Use Human Decay‐Accelerating Factor (DAF) as a Receptor Do Not Bind the Rodent Analogues of DAF
Author(s) -
O. Brad Spiller,
Ian Goodfellow,
David J. Evans,
Jeffrey W. Almond,
B. Paul Morgan
Publication year - 2000
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/315210
Subject(s) - decay accelerating factor , chinese hamster ovary cell , biology , virology , echovirus , coxsackievirus , transfection , hamster , microbiology and biotechnology , virus , receptor , complement system , enterovirus , antibody , cell culture , biochemistry , immunology , genetics
Many serotypes of echovirus (EV) and Coxsackie B virus (CBV) bind human decay-accelerating factor (DAF) and use it as a receptor for infection. Analogues for DAF have been isolated from mice and rats and characterized; these analogues have amino acid identities to human DAF of approximately 60%. EV serotypes 3, 6', 7, 11-13, and 29 and CBV serotypes 1, 3, and 5 caused hemagglutination of human erythrocytes but not rat or mouse erythrocytes, suggesting failure to bind rodent DAF. To confirm this evidence, radiolabeled viruses were incubated with transfected Chinese hamster ovary (CHO) cells that were abundantly expressing each type of DAF. Only cells that expressed human DAF bound virus. Although binding of EV and CBV was specific for human DAF, complement inhibition by DAF expressed in CHO cells was similar for each analogue.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom